Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 1998 May 23;316(7144):1606-7.
doi: 10.1136/bmj.316.7144.1606a.

Intermittent low dose prednisolone is safe in rheumatoid arthritis

P C Gøtzsche, H K Johansen
Comment

Intermittent low dose prednisolone is safe in rheumatoid arthritis

P C Gøtzsche et al. BMJ. .
No abstract available

PubMed Disclaimer

Comment on

References

    1. Gøtzsche PC, Johansen HK. Meta-analysis of short term low dose prednisolone versus placebo and non-steroidal, anti-inflammatory drugs in rheumatoid arthritis. BMJ. 1998;316:811–818. . (14 March.) - PMC - PubMed
    1. Dennison EM, Cooper C. Corticosteroids in rheumatoid arthritis. BMJ. 1998;316:789–790. . (14 March.) - PMC - PubMed
    1. Eastel R.on behalf of the UK consensus group meeting on osteoporosis. J Intern Med 1995237439–447. - PubMed
    1. Verhoeven AC, Boers M. Limited bone loss due to corticosteroids: a systematic review of prospective studies in rheumatoid arthritis and other diseases. J Rheumatol. 1997;24:1495–1503. - PubMed
    1. Boers M, Verhoeven AC, Markussen HM, Laar AFJ van de, Westhovens R, Denderen JC van, et al. Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis. Lancet. 1997;350:309–318. - PubMed

MeSH terms

Substances